research LB1056 Phase 1b: Translational evaluation of VYN201, a pan-BD BET inhibitor, for the treatment of non-segmental vitiligo
VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.
Search
for
Sort by
Research
120-150 / 1000+ resultsresearch Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.
research Forthcoming Issues
research Ablative 2940 nm Er: YAG fractional laser for male androgenetic alopecia
research CFTR potentiator ivacaftor protects against noise-induced hair cell loss by increasing Nrf2 and reducing oxidative stress
Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.
research In vivo Study of the Effect of 5 and 10% Nebivolol Cream on Hair Growth in Mice Models
Nebivolol cream may be a promising hair loss treatment by improving blood flow and nourishing hair follicles.
research Review of the XIV International Congress of the Italian Society of Hair Restoration
Unable to summarize as the text provided does not contain a conclusion.
research Evaluation of the efficacy of a food supplement on hair trophism and normal growth in subjects with androgenetic alopecia
The supplement may improve hair growth and quality in women with mild to moderate hair loss.
research 10.1063/5.0132123.1
research Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent females / supplemental files
research Editorial
research Editorial
research Editorial
research International Meeting – Rome
I cannot provide a summary without the content of the document.
research ABHRS holds exam in Capri, Italy
The ABHRS held a test in Capri, Italy.
research A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
Latanoprost 0.1% may effectively treat hair loss.
research Flurandrenolide
research A randomized double-blind placebo-controlled clinical trial to evaluate the effect of an Annurca apple supplement formula in androgenic alopecia
The Annurca apple supplement significantly improved hair growth in people with hair loss.
research Study of two different formulations of finasteride in male volunteers with androgenetic alopecia
research Vacuum Therapy in Association with Plant ActiveCompounds, Prebiotics and Probiotics for Treatment ofAndrogenetic Alopecia, Female Pattern Hair Loss andTelogen Effluvium, Part II: Follow-up Study
The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.
research Dietary supplementation with Essential-oils-cobalt for improving growth performance, meat quality and skin cell capacity of goats
Essential-oils-cobalt improves goat growth and product quality.
research AnnoPharma: Detection of substances responsible of ADR by annotating and extracting information from MEDLINE abstracts
AnnoPharma effectively identifies substances causing adverse drug reactions in medical abstracts.
research Efficacy and safety of ozenoxacin 1% cream, a novel antibiotic for the topical treatment of impetigo in children and adults
Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.
research PROCEEDINGS OF THE INTERNATIONAL RESEARCH, EDUCATION & TRAINING CENTER
research Contents Vol. 231, 2015
The document covers various dermatological treatments and conditions.
research Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.
research A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia
IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.
research 22
research A COMPARISON OF AN HERBAL DRUG AND 2% MINOXIDIL SOLUTION IN THE TREATMENT OF THE ANDROGENETIC ALOPECIA
research Topical application of the Wnt/β-catenin activator methyl vanillate increases hair count and hair mass index in women with androgenetic alopecia
Methyl vanillate spray increases hair count and hair mass in women with hair loss.